Bleeding rates with severe hemophilia A fall with prophylaxis: Study
Prophylactic, or preventive, treatment with factor VIII (FVIII) replacement therapy for four years reduced annual bleeding rates by 91% for...
admin
Phase 2 Study Evaluates Serplulimab Plus HLX04 as First-Line Treatment for Advanced Hepatocellular Carcinoma
An open-label, multicenter phase 2 study (NCT03973112) conducted in China aimed to investigate the safety and initial effectiveness of serplulimab...
Artificial intelligence in neuro-oncology: advances and challenges in brain tumor diagnosis, prognosis, and precision treatment
Brain tumors - classifications, symptoms, diagnosis and treatments. https://www.aans.org/en/Patients/Neurosurgical-Conditions-and-Treatments/Brain-Tumors.Fan, Y. et al. Burden and trends of brain and central nervous...
Walden Biosciences Highlights 2024 Accomplishments and 2025
Fully Enrolled Second Cohort in Phase 2 Basket Study of WAL0921 In Chronic Kidney Disease Plans to Initiate Rare Kidney...
Coding and documentation for Y-90 radioembolization
The treatment of liver tumors using yttrium-90 (Y-90) radioembolization brings unusual challenges for interventional radiologists. Documentation of treatment planning, calculation...
Three-pronged treatment improves prognosis for inoperable liver cancer | Science
If decades and decades of cancer research have shown anything, it is that there is no magic bullet to defeat...
